Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency

<p>Abstract</p> <p>Background</p> <p>Treatment of tumors with macromolecular toxins directed to cytoplasmic targets requires selective endocytosis followed by release of intact toxin from the endosomal/lysosomal compartment. The latter step remains a particular challeng...

Full description

Bibliographic Details
Main Authors: Howell Stephen B, Manorek Gerald, Lin Xinjian, Yuan Xiaoqin
Format: Article
Language:English
Published: BMC 2011-02-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/11/61
id doaj-f2575a190429422f83749b6400cebd4e
record_format Article
spelling doaj-f2575a190429422f83749b6400cebd4e2020-11-24T22:16:23ZengBMCBMC Cancer1471-24072011-02-011116110.1186/1471-2407-11-61Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potencyHowell Stephen BManorek GeraldLin XinjianYuan Xiaoqin<p>Abstract</p> <p>Background</p> <p>Treatment of tumors with macromolecular toxins directed to cytoplasmic targets requires selective endocytosis followed by release of intact toxin from the endosomal/lysosomal compartment. The latter step remains a particular challenge. Claudins 3 and 4 are tight junction proteins that are over-expressed in many types of tumors. This study utilized the C-terminal 30 amino acid fragment of <it>C. perfringens </it>enterotoxin (CPE), which binds to claudins 3 and 4, to deliver a toxin in the form of recombinant gelonin (rGel) to the cytoplasm of the human ovarian carcinoma cell line 2008.</p> <p>Results</p> <p>CPE was fused to rGel at its N-terminal end via a flexible G<sub>4</sub>S linker. This CPE-G<sub>4</sub>S-rGel molecule was internalized into vesicles from which location it produced little cytotoxicity. To enhance release from the endosomal/lysosomal compartment a poly-arginine sequence (R<sub>9</sub>) was introduced between the CPE and the rGel. CPE-R<sub>9</sub>-rGel was 10-fold more cytotoxic but selectivity for claudin-expressing cells was lost. The addition of a poly-glutamic acid sequence (E<sub>9</sub>) through a G<sub>4</sub>S linker to R<sub>9</sub>-rGel (E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel) largely neutralized the non-selective cell membrane penetrating activity of the R<sub>9 </sub>motif. However, introduction of CPE to the E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel fusion protein (CPE-E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel) further reduced its cytotoxic effect. Treatment with the endosomolytic reagent chloroquine increased the cytotoxicity of CPE-E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel. Several types of linkers susceptible to cleavage by furin and endosomal cathepsin B were tested for their ability to enhance R<sub>9</sub>-rGel release but none of these modifications further enhanced the cytotoxicity of CPE-E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel.</p> <p>Conclusion</p> <p>We conclude that while a claudin-3 and -4 ligand serves to deliver rGel into 2008 cells the delivered molecules were entrapped in intracellular vesicles. Incorporation of R<sub>9 </sub>non-specifically increased rGel cytotoxicity and this effect could be masked by inclusion of an E9 sequence. However, the putative protease cleavable sequences tested were inadequate for release of R<sub>9</sub>-rGel from CPE-E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel.</p> http://www.biomedcentral.com/1471-2407/11/61
collection DOAJ
language English
format Article
sources DOAJ
author Howell Stephen B
Manorek Gerald
Lin Xinjian
Yuan Xiaoqin
spellingShingle Howell Stephen B
Manorek Gerald
Lin Xinjian
Yuan Xiaoqin
Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency
BMC Cancer
author_facet Howell Stephen B
Manorek Gerald
Lin Xinjian
Yuan Xiaoqin
author_sort Howell Stephen B
title Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency
title_short Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency
title_full Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency
title_fullStr Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency
title_full_unstemmed Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency
title_sort challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2011-02-01
description <p>Abstract</p> <p>Background</p> <p>Treatment of tumors with macromolecular toxins directed to cytoplasmic targets requires selective endocytosis followed by release of intact toxin from the endosomal/lysosomal compartment. The latter step remains a particular challenge. Claudins 3 and 4 are tight junction proteins that are over-expressed in many types of tumors. This study utilized the C-terminal 30 amino acid fragment of <it>C. perfringens </it>enterotoxin (CPE), which binds to claudins 3 and 4, to deliver a toxin in the form of recombinant gelonin (rGel) to the cytoplasm of the human ovarian carcinoma cell line 2008.</p> <p>Results</p> <p>CPE was fused to rGel at its N-terminal end via a flexible G<sub>4</sub>S linker. This CPE-G<sub>4</sub>S-rGel molecule was internalized into vesicles from which location it produced little cytotoxicity. To enhance release from the endosomal/lysosomal compartment a poly-arginine sequence (R<sub>9</sub>) was introduced between the CPE and the rGel. CPE-R<sub>9</sub>-rGel was 10-fold more cytotoxic but selectivity for claudin-expressing cells was lost. The addition of a poly-glutamic acid sequence (E<sub>9</sub>) through a G<sub>4</sub>S linker to R<sub>9</sub>-rGel (E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel) largely neutralized the non-selective cell membrane penetrating activity of the R<sub>9 </sub>motif. However, introduction of CPE to the E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel fusion protein (CPE-E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel) further reduced its cytotoxic effect. Treatment with the endosomolytic reagent chloroquine increased the cytotoxicity of CPE-E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel. Several types of linkers susceptible to cleavage by furin and endosomal cathepsin B were tested for their ability to enhance R<sub>9</sub>-rGel release but none of these modifications further enhanced the cytotoxicity of CPE-E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel.</p> <p>Conclusion</p> <p>We conclude that while a claudin-3 and -4 ligand serves to deliver rGel into 2008 cells the delivered molecules were entrapped in intracellular vesicles. Incorporation of R<sub>9 </sub>non-specifically increased rGel cytotoxicity and this effect could be masked by inclusion of an E9 sequence. However, the putative protease cleavable sequences tested were inadequate for release of R<sub>9</sub>-rGel from CPE-E<sub>9</sub>-G<sub>4</sub>S-R<sub>9</sub>-rGel.</p>
url http://www.biomedcentral.com/1471-2407/11/61
work_keys_str_mv AT howellstephenb challengesassociatedwiththetargeteddeliveryofgelonintoclaudinexpressingcancercellswiththeuseofactivatablecellpenetratingpeptidestoenhancepotency
AT manorekgerald challengesassociatedwiththetargeteddeliveryofgelonintoclaudinexpressingcancercellswiththeuseofactivatablecellpenetratingpeptidestoenhancepotency
AT linxinjian challengesassociatedwiththetargeteddeliveryofgelonintoclaudinexpressingcancercellswiththeuseofactivatablecellpenetratingpeptidestoenhancepotency
AT yuanxiaoqin challengesassociatedwiththetargeteddeliveryofgelonintoclaudinexpressingcancercellswiththeuseofactivatablecellpenetratingpeptidestoenhancepotency
_version_ 1725790294819995648